Early Immune Dysregulation Emerges During the Advanced Adenoma–Carcinoma Transition Through PD-1/PD-L1 Checkpoint Remodeling
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Dysregulation of immune checkpoints, particularly PD-1 and PD-L1, drives colorectal cancer (CRC) progression. This case–control study investigated the stage- and sex-dependent transcriptional and epigenetic dynamics of PDCD1 (PD-1) and CD274 (PD-L1) across the normal–advanced adenoma (ACA)–CRC sequence, and evaluated their correlation with tumor-infiltrating lymphocytes (TILs). Quantitative RT-PCR and digestion-based promoter methylation assays (using Hpa II/ Msp I) were performed on tissue specimens. We demonstrate a progressive transcriptional divergence: PD-1 expression significantly decreased from normal mucosa to ACA and CRC, whereas PD-L1 expression increased, peaking in CRC. This PD-L1 upregulation correlated with decreased exon methylation in ACA, indicating early epigenetic derepression. Notably, female ACA tissues exhibited significantly higher PD-L1 expression than male counterparts, highlighting early sex-specific immune modulation. Correlation analyses revealed progressive uncoupling of PD-1/PD-L1 expression and stage-specific shifts in methylation patterns. Furthermore, PD-1 methylation positively correlated with TIL density specifically in ACA, whereas lifestyle confounders showed no significant association. These findings reveal that PD-1 and PD-L1 undergo distinct transcriptional and epigenetic remodeling during early colorectal neoplasia. The identification of early sex-specific PD-L1 upregulation and altered expression-methylation coupling offers potential biomarkers and targets for early-stage immunotherapeutic intervention.
Source: Research Square
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7204918436
